Dare Bioscience (DARE) Misses Q1 EPS by 1c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $9.3 million versus the consensus estimate of $173.67 thousand.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc. (XP) Tops Q2 EPS by 8c
• Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules